ArticleClinical immunology (Orlando, Fla.)2022

Seroconversion among rituximab-treated patients following SARS-CoV-2 vaccine supplemental dose.

Emily Rose et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.